Magnitude and Variability of the Glucagon-Like Peptide-1 Response in Patients With Type 2 Diabetes Up to 2 Years Following Gastric Bypass Surgery

Diabetes Care - United States
doi 10.2337/dc11-1472
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Resolution of Type 2 Diabetes Following Gastric Bypass Surgery: Involvement of Gut-Derived Glucagon and Glucagonotropic Signalling?

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2009English

Impaired Cardiometabolic Responses to Glucagon-Like Peptide 1 in Obesity and Type 2 Diabetes Mellitus

Basic Research in Cardiology
Cardiovascular MedicinePhysiologyCardiology
2013English

Glucagon-Like Peptide Analogues for Type 2 Diabetes Mellitus

2007English

Glucagon-Like Peptide 1 Receptor Agonists: A New Approach to Type 2 Diabetes Management

South African Family Practice
2013English

Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1-Stimulated Postprandial Insulin Secretion in Humans

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Correction To: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features

Clinical Drug Investigation
MedicinePharmacology
2020English

Glucagon-Like Peptide-1 (GLP-1) Receptors Are Not Overexpressed in Pancreatic Islets From Patients With Severe Hyperinsulinaemic Hypoglycaemia Following Gastric Bypass

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Gastric Bypass Surgery Reveals Independency of Obesity and Diabetes Melitus Type 2

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2016English

Liver ENPP1 Protein Increases With Remission of Type 2 Diabetes After Gastric Bypass Surgery

BMC Gastroenterology
MedicineGastroenterology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy